Description: Aarti Industries Limited manufactures and sells specialty chemicals and pharmaceuticals in India. It offers di chloro benzene, nitro chloro and nitro benzene, nitro toluenes, sulphur, and other organic and inorganic products that are used in the manufacture of intermediates with applications in agrochemicals, pharmaceuticals, polymer additives, fuel additives, FMCG, dyes, printing inks, pigments, rubber chemicals, and other speciality chemical applications. The company also provides active pharmaceutical ingredients, which have applications in anti-hypertensive, anti asthamatic, anti-cancer, anti thalassaemic, analgesic, ophthalmologic, and calcimimetics; central nervous system agents; and skin care and decongestant products. In addition, it offers intermediates; and xanthine derivatives, such as caffeine theophylline anhydrous, aminophylline, etophylline, theobromine, acephylline piperazine, and theobromine derivatives, as well as contract manufacturing and research services. The company also exports its products to approximately 60 countries in North America, Europe, China, Japan, and internationally. Aarti Industries Limited was founded in 1975 and is headquartered in Mumbai, India.
Home Page: www.aarti-industries.com
Officers
| Name | Title |
|---|---|
| Mr. Rajendra Vallabhaji Gogri | Chairman & MD |
| Mr. Rashesh Chandrakanth Gogri | Vice Chairman & MD |
| Mr. Kirit R. Mehta | Whole Time Director |
| Ms. Hetal Gala Gogri | Whole Time Director |
| Mr. Parimal Hasmukhlal Desai | Whole Time Director |
Exchange: BSE
Country: IN : India
Currency: Indian Rupee (INR)
| Forward PE: | 23.6967 |
|---|---|
| Trailing PE: | 21.5589 |
| Price-to-Book MRQ: | 5.0901 |
| Price-to-Sales TTM: | 3.5006 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 0 |